نتائج البحث - "Hansson, Markus"

1

Preliminary Dose-Escalation Results from a Phase 1/2 Study of GEN3014 (HexaBody (R)-CD38) in Patients (pts) with Relapsed or Refractory Multiple Myeloma (RRMM)

المؤلفون: Spencer, Andrew, Iversen, Katrine Fladeland, Dhakal, Binod, Creignou, Maria, Chen, Jenny, Hiemstra, Ida H, Bosgra, Sieto, Badani, Avani, Breij, Esther C. W., Brady, Lauren K., Sasser, A. Kate, Malmberg, Anders, Gregersen, Henrik, Hansson, Markus, Broijl, Annemiek, Mateos, Maria-Victoria, Plesner, Torben

المصدر: Spencer, A, Iversen, K F, Dhakal, B, Creignou, M, Chen, J, Hiemstra, I H, Bosgra, S, Badani, A, Breij, E C W, Brady, L K, Sasser, A K, Malmberg, A, Gregersen, H, Hansson, M, Broijl, A, Mateos, M-V & Plesner, T 2022, ' Preliminary Dose-Escalation Results from a Phase 1/2 Study of GEN3014 (HexaBody (R)-CD38) in Patients (pts) with Relapsed or Refractory Multiple Myeloma (RRMM) ', Blood, vol. 140, no. Suppl. 1, pp. 7320-7321 . https://doi.org/10.1182/blood-2022-159116Test

مصطلحات موضوعية: Immunology, Cell Biology, Hematology, Biochemistry

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b634c32e365565dc436825a2676635ecTest
https://vbn.aau.dk/da/publications/d88f8ee9-5ede-47a7-916e-dd45078c17e3Test

2

Additional file 1 of Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission �� results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial

مصطلحات موضوعية: Data_FILES

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c09498058bd8b5862d915e049e9bcf6Test

3

Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

المؤلفون: Went, Molly, Sud, Amit, Försti, Asta, Halvarsson, Britt-Marie, Weinhold, Niels, Kimber, Scott, Van Duin, Mark, Thorleifsson, Gudmar, Holroyd, Amy, Johnson, David C, Li, Ni, Orlando, Giulia, Law, Philip J, Ali, Mina, Chen, Bowang, Mitchell, Jonathan S, Gudbjartsson, Daniel F, Kuiper, Rowan, Stephens, Owen W, Bertsch, Uta, Broderick, Peter, Campo, Chiara, Bandapalli, Obul R, Einsele, Hermann, Gregory, Walter A, Gullberg, Urban, Hillengass, Jens, Hoffmann, Per, Jackson, Graham H, Jöckel, Karl-Heinz, Johnsson, Ellinor, Kristinsson, Sigurður Y, Mellqvist, Ulf-Henrik, Nahi, Hareth, Easton, Douglas, Pharoah, Paul, Dunning, Alison, Peto, Julian, Canzian, Federico, Swerdlow, Anthony, Eeles, Rosalind A, Kote-Jarai, ZSofia, Muir, Kenneth, Pashayan, Nora, Nickel, Jolanta, Nöthen, Markus M, Rafnar, Thorunn, Ross, Fiona M, Da Silva Filho, Miguel Inacio, Thomsen, Hauke, Turesson, Ingemar, Vangsted, Annette, Andersen, Niels Frost, Waage, Anders, Walker, Brian A, Wihlborg, Anna-Karin, Broyl, Annemiek, Davies, Faith E, Thorsteinsdottir, Unnur, Langer, Christian, Hansson, Markus, Goldschmidt, Hartmut, Kaiser, Martin, Sonneveld, Pieter, Stefansson, Kari, Morgan, Gareth J, Hemminki, Kari, Nilsson, Björn, Houlston, Richard S, PRACTICAL Consortium

المساهمون: Sud, Amit [0000-0002-6133-0164], Johnson, David C [0000-0003-0887-3343], Law, Philip J [0000-0001-9663-4611], Gudbjartsson, Daniel F [0000-0002-5222-9857], Broderick, Peter [0000-0002-8348-5829], Bandapalli, Obul R [0000-0002-1132-1745], Easton, Douglas [0000-0003-2444-3247], Pharoah, Paul [0000-0001-8494-732X], Canzian, Federico [0000-0002-4261-4583], Eeles, Rosalind A [0000-0002-3698-6241], Muir, Kenneth [0000-0001-6429-988X], Pashayan, Nora [0000-0003-0843-2468], Hansson, Markus [0000-0002-7715-4548], Houlston, Richard S [0000-0002-5268-0242], Apollo - University of Cambridge Repository

المصدر: Nature Communications, Vol 9, Iss 1, Pp 1-10 (2018)

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d79b71242c8d25365962408d9c1611eTest
https://doaj.org/article/af73d8d01835421aac1fd29b48af6093Test

4

Incidence, mortality and survival in multiple myeloma compared to other hematopoietic neoplasms in Sweden up to year 2016

المؤلفون: Hemminki Kari Jussi, Försti Asta, Hansson Markus

المصدر: Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)

مصطلحات موضوعية: Male, Sweden, Databases, Factual, Science, Incidence, Health care, Survival in cancer, Middle Aged, Article, Survival Rate, Hematopoietic neoplasms, Hematologic Neoplasms, Medicine, Humans, Female, Registries, Mortality, Multiple Myeloma, Cancer, Aged

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::203fc33e4d0906f9237a8b9eeeef483cTest
http://europepmc.org/articles/PMC8390646Test

5

Carfilzomib and dexamethasone maintenance prolong time to progression following salvage ASCT in multiple myeloma

المصدر: Gregersen, H, Peceliunas, V, Remes, K, Schjesvold, F H, Abildgaard, N, Nahi, H, Andersen, N F, Vangsted, A J, Klausen, T W, Helleberg, C, Carlson, K, Frølund, U, Axelsson, P, Stromberg, O, Blimark, C, Linder, O, Tsykunova, G, Waage, A, Hansson, M & Guldbrandsen, N 2019, ' Carfilzomib and dexamethasone maintenance prolong time to progression following salvage ASCT in multiple myeloma ', 24th European Hematology Association Congress (EHA), Amsterdam, Netherlands, 13/06/2019-16/06/2019 . < https://library.ehaweb.org/eha/2019/24th/267356/henrik.gregersen.carfilzomib.and.dexamethasone.maintenance.prolong.time.to.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3Ds1602Test >

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______3062::214014fe155b5da149f4bd548ea67134Test
https://library.ehaweb.org/eha/2019/24th/267356/henrik.gregersen.carfilzomib.and.dexamethasone.maintenance.prolong.time.to.html?f=listing=0Test*browseby=8*sortby=1*search=s1602

6

Carfilzomib and dexamethasone maintenance prolong time to progression following salvage ASCT in multiple myeloma: A randomized phase 2 trial by the nordic myeloma study group

المصدر: Gregersen, H, Peceliunas, V, Remes, K, Schjesvold, F H, Abildgaard, N, Nahi, H, Andersen, N F, Vangsted, A J, Klausen, T W, Helleberg, C, Carlson, K, Frølund, U, Axelsson, P, Stromberg, O, Blimark, C, Linder, O, Tsykunova, G, Waage, A, Hansson, M & Guldbrandsen, N 2019, ' Carfilzomib and dexamethasone maintenance prolong time to progression following salvage ASCT in multiple myeloma: A randomized phase 2 trial by the nordic myeloma study group ', HemaSphere, vol. 3, S1602, pp. 737-738 . < https://journals.lww.com/hemasphere/Fulltext/2019/06001/CARFILZOMIB_AND_DEXAMETHASONE_MAINTENANCE_PROLONG.1480.aspxTest >

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______3062::b8d986d4947b6ead3ac84f45802ea533Test
https://portal.findresearcher.sdu.dk/da/publications/0a0699cb-b3fe-488b-93d2-7843a683b1f4Test